EWA
EverSource Wealth Advisors’s CRISPR Therapeutics CRSP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.52M | Buy |
92,943
+8,063
| +9% | +$392K | 0.2% | 102 |
|
|
2025
Q1 | $2.89M | Buy |
84,880
+84,708
| +49,249% | +$2.88M | 0.16% | 119 |
|
|
2024
Q4 | $6.77K | Sell |
172
-1,308
| -88% | -$51.5K | ﹤0.01% | 2198 |
|
|
2024
Q3 | $69.5K | Sell |
1,480
-1,092
| -42% | -$51.3K | ﹤0.01% | 926 |
|
|
2024
Q2 | $147K | Buy |
2,572
+710
| +38% | +$40.7K | 0.01% | 668 |
|
|
2024
Q1 | $98.7K | Buy |
1,862
+446
| +31% | +$23.6K | 0.01% | 715 |
|
|
2023
Q4 | $88.6K | Buy |
1,416
+366
| +35% | +$22.9K | 0.01% | 684 |
|
|
2023
Q3 | $47.7K | Buy |
1,050
+82
| +8% | +$3.72K | 0.01% | 824 |
|
|
2023
Q2 | $54.3K | Buy |
968
+915
| +1,726% | +$51.4K | 0.01% | 803 |
|
|
2023
Q1 | $2.4K | Buy |
53
+28
| +112% | +$1.27K | ﹤0.01% | 1883 |
|
|
2022
Q4 | $1.02K | Sell |
25
-356
| -93% | -$14.5K | ﹤0.01% | 2084 |
|
|
2022
Q3 | $25K | Buy |
381
+366
| +2,440% | +$24K | 0.01% | 827 |
|
|
2022
Q2 | $1K | Buy |
+15
| New | +$1K | ﹤0.01% | 1622 |
|
|
2022
Q1 | – | Sell |
-34
| Closed | -$3K | – | 1732 |
|
|
2021
Q4 | $3K | Buy |
+34
| New | +$3K | ﹤0.01% | 1405 |
|